Variant report

Variant	esv3438105
Chromosome Location	chr1:246956529-246958527
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:29)
CpG islands
(count:61)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:29 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr1:246958086-246958377	K562	blood:	n/a	n/a
2	CHD2	chr1:246958101-246958430	Hela-S3	cervix:	n/a	n/a
3	FOS	chr1:246958127-246958396	MCF10A-Er-Src	breast:	n/a	chr1:246958243-246958251 chr1:246958242-246958252
4	FOS	chr1:246958135-246958378	MCF10A-Er-Src	breast:	n/a	chr1:246958243-246958251 chr1:246958242-246958252
5	FOS	chr1:246958151-246958318	MCF10A-Er-Src	breast:	n/a	chr1:246958243-246958251 chr1:246958242-246958252
6	JUND	chr1:246958201-246958239	K562	blood:	n/a	n/a
7	MAX	chr1:246958135-246958243	HepG2	liver:	n/a	n/a
8	MAX	chr1:246958038-246958361	NB4	blood:	n/a	n/a
9	MAX	chr1:246958122-246958498	Hela-S3	cervix:	n/a	n/a
10	MAX	chr1:246958454-246959107	H1-hESC	embryonic stem cell:	n/a	n/a
11	MAZ	chr1:246958175-246958319	HepG2	liver:	n/a	n/a
12	MAZ	chr1:246958304-246958360	K562	blood:	n/a	n/a
13	MAZ	chr1:246958177-246958429	Hela-S3	cervix:	n/a	n/a
14	MYC	chr1:246958192-246958447	MCF10A-Er-Src	breast:	n/a	n/a
15	MYC	chr1:246958248-246958257	K562	blood:	n/a	n/a
16	MYC	chr1:246958061-246958370	NB4	blood:	n/a	n/a
17	POLR2A	chr1:246958235-246958468	Hela-S3	cervix:	n/a	n/a
18	POLR2A	chr1:246957946-246957949	HepG2	liver:	n/a	n/a
19	POLR2A	chr1:246955911-246956546	HepG2	liver:	n/a	n/a
20	POLR2A	chr1:246956803-246957071	HepG2	liver:	n/a	n/a
21	RCOR1	chr1:246958014-246958344	Hela-S3	cervix:	n/a	n/a
22	REST	chr1:246957685-246957881	Hela-S3	cervix:	n/a	chr1:246957817-246957825 chr1:246957807-246957816
23	SMARCC1	chr1:246957587-246958575	Hela-S3	cervix:	n/a	chr1:246958242-246958251
24	SMC3	chr1:246958057-246958430	Hela-S3	cervix:	n/a	n/a
25	STAT3	chr1:246958179-246958432	MCF10A-Er-Src	breast:	n/a	n/a
26	STAT3	chr1:246958169-246958432	MCF10A-Er-Src	breast:	n/a	n/a
27	TFAP2C	chr1:246957833-246958600	Hela-S3	cervix:	n/a	n/a
28	USF1	chr1:246958508-246959063	H1-hESC	embryonic stem cell:	n/a	n/a
29	USF2	chr1:246958064-246958352	Hela-S3	cervix:	n/a	chr1:246958183-246958194

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:246958421-246958471	RPTEC	kidney:	n/a
2	chr1:246958421-246958471	AG10803	skin:	n/a
3	chr1:246958421-246958471	NH-A	brain:	n/a
4	chr1:246958421-246958471	HL-60	blood:	n/a
5	chr1:246958421-246958471	AG09319	gingival:	n/a
6	chr1:246958421-246958471	HUVEC	blood vessel:	n/a
7	chr1:246958421-246958471	ECC-1	luminal epithelium:	n/a
8	chr1:246958421-246958471	LNCaP	prostate:	n/a
9	chr1:246958421-246958471	Hela-S3	cervix:	n/a
10	chr1:246958421-246958471	GM12891	blood:	n/a
11	chr1:246958421-246958471	HepG2	liver:	n/a
12	chr1:246958421-246958471	HEEpiC	esophagus:	n/a
13	chr1:246958421-246958471	GM19239	blood:	n/a
14	chr1:246958421-246958471	NHDF-neo	bronchial:	n/a
15	chr1:246958421-246958471	SK-N-SH	brain:	n/a
16	chr1:246958421-246958471	MCF-7	breast:	n/a
17	chr1:246958421-246958471	NB4	blood:	n/a
18	chr1:246958421-246958471	GM06990	blood:	n/a
19	chr1:246958421-246958471	HEK293	kidney:	embryo
20	chr1:246958421-246958471	PrEC	prostate:	n/a
21	chr1:246958421-246958471	GM12878	blood:	n/a
22	chr1:246958421-246958471	ProgFib	skin:	n/a
23	chr1:246958421-246958471	ovcar-3	ovarian:	n/a
24	chr1:246958421-246958471	HPAEpiC	pulmonary alveolar:	n/a
25	chr1:246958421-246958471	NT2-D1	testis:	n/a
26	chr1:246958421-246958471	AoSMC	blood vessel:	n/a
27	chr1:246958421-246958471	HAEpiC	amniotic membrane:	n/a
28	chr1:246958421-246958471	HMEC	breast:	n/a
29	chr1:246958421-246958471	HNPCEpiC	eye:	n/a
30	chr1:246958421-246958471	H1-hESC	embryonic stem cell:	embryo
31	chr1:246958421-246958471	AG04449	skin:	fetal
32	chr1:246958421-246958471	HRCEpiC	kidney:	n/a
33	chr1:246958421-246958471	A549	lung:	n/a
34	chr1:246958421-246958471	HRE	kidney:	n/a
35	chr1:246958421-246958471	Jurkat	blood:	n/a
36	chr1:246958421-246958471	Caco-2	colon:	n/a
37	chr1:246958421-246958471	SK-N-SH_RA	brain:	n/a
38	chr1:246958421-246958471	HCT-116	colon:	n/a
39	chr1:246958421-246958471	GM12892	blood:	n/a
40	chr1:246958421-246958471	CMK	blood:	n/a
41	chr1:246958421-246958471	K562	blood:	n/a
42	chr1:246958421-246958471	AG04450	lung:	fetal
43	chr1:246958421-246958471	AG09309	skin:	n/a
44	chr1:246958421-246958471	IMR90	lung:	fetal
45	chr1:246958421-246958471	NHBE	bronchial:	n/a
46	chr1:246958421-246958471	SKMC	muscle:	n/a
47	chr1:246958421-246958471	BJ	skin:	n/a
48	chr1:246958421-246958471	Hepatocyte	liver:	n/a
49	chr1:246958421-246958471	MCF10A-Er-Src	breast:	n/a
50	chr1:246958421-246958471	HRPEpiC	eye:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr1:246947863..246950737-chr1:246955534..246958026,3	K562	blood:

No data

Variant related genes	Relation type
KIF28P	TF binding region
KIF28P	CpG island

Extended variants
information (count: 78 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:78 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111427807	chr1:246956544-246956545	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs563822883	chr1:246956548-246956549	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs189416733	chr1:246956565-246956566	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs150096388	chr1:246956602-246956603	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs559667950	chr1:246956619-246956620	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs528434605	chr1:246956639-246956640	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs181054755	chr1:246956660-246956661	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs10924832	chr1:246956699-246956700	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs530741708	chr1:246956755-246956756	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs550369400	chr1:246956775-246956776	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs12047935	chr1:246956787-246956788	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs187277850	chr1:246956795-246956796	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs535830914	chr1:246956887-246956888	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs372243324	chr1:246956900-246956901	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs376645615	chr1:246956907-246956908	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs567749996	chr1:246956915-246956916	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs552591187	chr1:246956958-246956959	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs143583308	chr1:246956962-246956963	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs185679677	chr1:246956977-246956978	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs578086730	chr1:246957037-246957038	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs544019577	chr1:246957040-246957041	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs367787102	chr1:246957044-246957045	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs562907772	chr1:246957059-246957060	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs190902150	chr1:246957065-246957066	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs386641770	chr1:246957066-246957067	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs78750707	chr1:246957067-246957068	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs12122102	chr1:246957154-246957155	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs528497551	chr1:246957188-246957189	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs77938284	chr1:246957240-246957241	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs12752708	chr1:246957294-246957295	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs530089956	chr1:246957418-246957419	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs72191060	chr1:246957425-246957426	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs12075623	chr1:246957514-246957515	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs530597883	chr1:246957536-246957537	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs550786659	chr1:246957584-246957585	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs185912979	chr1:246957606-246957607	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs542548291	chr1:246957631-246957632	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs201573467	chr1:246957632-246957633	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs546294433	chr1:246957643-246957644	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs373902055	chr1:246957680-246957681	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs143599987	chr1:246957681-246957682	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs147187432	chr1:246957684-246957685	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs375490562	chr1:246957689-246957690	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs190675369	chr1:246957717-246957718	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs571933723	chr1:246957730-246957731	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs537229581	chr1:246957737-246957738	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs557570606	chr1:246957784-246957785	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs114564919	chr1:246957785-246957786	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs183253363	chr1:246957861-246957862	Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs553512052	chr1:246957862-246957863	Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Neuroblastoma	21899760	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	20729466	CNVD
Testicular germ cell tumor	18059402	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Basal cell lymphoma	17170743	CNVD
Basal cell lymphoma	17053054	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Mental retardation	21549014	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164920	CNVD
Cancer	17060936	CNVD
abnormal development	18461090	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-small cell lung cancer	21829676	CNVD
Multiple myeloma	16616336	CNVD
Ovarian cancer	21720365	CNVD
Glioblastoma multiforme	22291905	CNVD
Myelofibrosis	22110671	CNVD
Disease	21936942	CNVD
laryngomalacia	21936942	CNVD
GLUT3 deficiency syndrome	20509907	CNVD
Developmental delay	21373258	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Developmental delay	19490664	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Cutaneous malignant melanoma	18794153	CNVD
Astrocytoma	17934521	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Breast cancer	20409316	CNVD
Fibroblasts	17951408	CNVD
Lung cancer	17951408	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD

Chromatin state (count:166 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:246946200-246956800	Weak transcription	Left Ventricle	heart
2	chr1:246949000-246957600	Weak transcription	NHDF-Ad	bronchial
3	chr1:246949400-246956800	Weak transcription	Hela-S3	cervix
4	chr1:246949400-246957600	Weak transcription	NHLF	lung
5	chr1:246952600-246956800	Weak transcription	Primary monocytes fromperipheralblood	blood
6	chr1:246952600-246957600	Weak transcription	Rectal Mucosa Donor 31	rectum
7	chr1:246952600-246957800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
8	chr1:246952800-246956600	Weak transcription	Placenta	Placenta
9	chr1:246952800-246956800	Weak transcription	Fetal Intestine Large	intestine
10	chr1:246952800-246957000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
11	chr1:246952800-246957000	Weak transcription	Brain Germinal Matrix	brain
12	chr1:246952800-246957600	Weak transcription	Fetal Brain Female	brain
13	chr1:246952800-246957800	Weak transcription	Monocytes-CD14+_RO01746	blood
14	chr1:246953000-246956800	Weak transcription	Fetal Brain Male	brain
15	chr1:246953000-246957600	Weak transcription	Fetal Heart	heart
16	chr1:246953000-246957600	Weak transcription	Placenta Amnion	Placenta Amnion
17	chr1:246953000-246957600	Weak transcription	Right Ventricle	heart
18	chr1:246953000-246957800	Weak transcription	Fetal Intestine Small	intestine
19	chr1:246953200-246956800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr1:246953200-246957600	Weak transcription	Spleen	Spleen
21	chr1:246953400-246956600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr1:246953400-246956600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
23	chr1:246953400-246956800	Weak transcription	Fetal Muscle Leg	muscle
24	chr1:246953400-246957000	Weak transcription	Gastric	stomach
25	chr1:246953400-246957600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr1:246953400-246957600	Weak transcription	Fetal Lung	lung
27	chr1:246953400-246957600	Weak transcription	Ovary	ovary
28	chr1:246953400-246958000	Weak transcription	Fetal Kidney	kidney
29	chr1:246953400-246961600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
30	chr1:246953600-246956800	Weak transcription	Fetal Stomach	stomach
31	chr1:246954800-246957600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr1:246955600-246959400	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr1:246956000-246956800	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr1:246956000-246957600	Enhancers	HUES6 Cell Line	embryonic stem cell
35	chr1:246956200-246957400	Enhancers	ES-I3 Cell Line	embryonic stem cell
36	chr1:246956200-246959000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr1:246956200-246959200	Enhancers	HUES64 Cell Line	embryonic stem cell
38	chr1:246956200-246959400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
39	chr1:246956400-246956800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
40	chr1:246956400-246956800	Bivalent Enhancer	K562	blood
41	chr1:246956400-246957000	Enhancers	A549	lung
42	chr1:246956400-246958400	Enhancers	H9 Cell Line	embryonic stem cell
43	chr1:246956400-246958600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr1:246956400-246959200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
45	chr1:246956400-246959200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
46	chr1:246956400-246959200	Enhancers	iPS-20b Cell Line	embryonic stem cell
47	chr1:246956400-246959400	Enhancers	HUES48 Cell Line	embryonic stem cell
48	chr1:246956400-246959400	Enhancers	iPS-18 Cell Line	embryonic stem cell
49	chr1:246956400-246959800	Enhancers	H1 Cell Line	embryonic stem cell
50	chr1:246956600-246956800	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links